Who are Glycomine www.glycomine.com's investors?

Glycomine www.glycomine.com's investors include Advent Life Sciences, Mission Bay Capital, Mission Biocapital, Remiges Ventures, Inc., RiverVest Venture Partners, Sanderling Ventures, Sanofi Ventures.

Glycomine www.glycomine.com

26 employees on LinkedIn · 7 known investors

Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options. The company focuses on addressing unmet medical needs in the rare disease space.

Biotech

Founders & leadership

Steven AxonChief Executive Officer

Hicham AlaouiChief Scientific Officer

Rose MarinoChief Medical Officer

Peter McWilliamsChief Business OfficerVenture Partner at Sanderling Ventures

Geoffrey HirdChief Technology Officer

Investors · 7

Advent Life SciencesLondon

Mission Bay CapitalSan Francisco

Mission BiocapitalSan Francisco · $500K

Remiges Ventures, Inc.Seattle

RiverVest Venture PartnersSt. Louis · $500K – $3M

Sanderling VenturesSan Mateo · $50K – $1M

Sanofi VenturesCambridge · $5M

Competitors · 1

by search overlap

Myriad10 shared keywordsMyriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.

Companies competing with Glycomine www.glycomine.com for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Glycomine www.glycomine.com do?: Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options. The company focuses on addressing unmet medical needs in the rare disease space.
Who are Glycomine www.glycomine.com's investors?: Glycomine www.glycomine.com's investors include Advent Life Sciences, Mission Bay Capital, Mission Biocapital, Remiges Ventures, Inc., RiverVest Venture Partners, Sanderling Ventures, Sanofi Ventures.